Logo image of CGC

CANOPY GROWTH CORP (CGC) Stock Fundamental Analysis

USA - NASDAQ:CGC - CA1380357048 - Common Stock

1.17 USD
+0.08 (+7.34%)
Last: 11/7/2025, 8:00:00 PM
1.1718 USD
+0 (+0.15%)
After Hours: 11/7/2025, 8:00:00 PM
Fundamental Rating

2

Taking everything into account, CGC scores 2 out of 10 in our fundamental rating. CGC was compared to 192 industry peers in the Pharmaceuticals industry. CGC has a bad profitability rating. Also its financial health evaluation is rather negative. CGC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CGC has reported negative net income.
CGC had a negative operating cash flow in the past year.
In the past 5 years CGC always reported negative net income.
In the past 5 years CGC always reported negative operating cash flow.
CGC Yearly Net Income VS EBIT VS OCF VS FCFCGC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1B -2B -3B

1.2 Ratios

CGC has a Return On Assets of -56.65%. This is in the lower half of the industry: CGC underperforms 61.98% of its industry peers.
CGC has a Return On Equity of -104.81%. This is in the lower half of the industry: CGC underperforms 62.50% of its industry peers.
Industry RankSector Rank
ROA -56.65%
ROE -104.81%
ROIC N/A
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
CGC Yearly ROA, ROE, ROICCGC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400

1.3 Margins

CGC has a Gross Margin (27.83%) which is in line with its industry peers.
The Profit Margin and Operating Margin are not available for CGC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CGC Yearly Profit, Operating, Gross MarginsCGC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800

More info and screens

3

2. Health

2.1 Basic Checks

CGC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CGC has more shares outstanding
Compared to 5 years ago, CGC has less shares outstanding
Compared to 1 year ago, CGC has an improved debt to assets ratio.
CGC Yearly Shares OutstandingCGC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
CGC Yearly Total Debt VS Total AssetsCGC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

CGC has an Altman-Z score of -11.87. This is a bad value and indicates that CGC is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CGC (-11.87) is worse than 72.92% of its industry peers.
CGC has a Debt/Equity ratio of 0.63. This is a neutral value indicating CGC is somewhat dependend on debt financing.
CGC's Debt to Equity ratio of 0.63 is on the low side compared to the rest of the industry. CGC is outperformed by 67.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF N/A
Altman-Z -11.87
ROIC/WACCN/A
WACC11.44%
CGC Yearly LT Debt VS Equity VS FCFCGC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

CGC has a Current Ratio of 3.07. This indicates that CGC is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CGC (3.07) is comparable to the rest of the industry.
CGC has a Quick Ratio of 2.12. This indicates that CGC is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CGC (2.12) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.07
Quick Ratio 2.12
CGC Yearly Current Assets VS Current LiabilitesCGC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 55.18% over the past year.
Looking at the last year, CGC shows a decrease in Revenue. The Revenue has decreased by -4.25% in the last year.
The Revenue has been decreasing by -7.57% on average over the past years.
EPS 1Y (TTM)55.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.25%
Revenue 1Y (TTM)-4.25%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%8.94%

3.2 Future

CGC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.29% yearly.
Based on estimates for the next years, CGC will show a small growth in Revenue. The Revenue will grow by 7.24% on average per year.
EPS Next Y87.72%
EPS Next 2Y39.4%
EPS Next 3Y25.31%
EPS Next 5Y15.29%
Revenue Next Year8.32%
Revenue Next 2Y5.98%
Revenue Next 3Y7.52%
Revenue Next 5Y7.24%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CGC Yearly Revenue VS EstimatesCGC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M 500M
CGC Yearly EPS VS EstimatesCGC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -20 -40 -60

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CGC. In the last year negative earnings were reported.
Also next year CGC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CGC Price Earnings VS Forward Price EarningsCGC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CGC Per share dataCGC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2 -3

4.3 Compensation for Growth

A more expensive valuation may be justified as CGC's earnings are expected to grow with 25.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.4%
EPS Next 3Y25.31%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CGC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CANOPY GROWTH CORP

NASDAQ:CGC (11/7/2025, 8:00:00 PM)

After market: 1.1718 +0 (+0.15%)

1.17

+0.08 (+7.34%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)02-05 2026-02-05/bmo
Inst Owners5.58%
Inst Owner Change2.39%
Ins Owners0.13%
Ins Owner Change53.71%
Market Cap395.75M
Revenue(TTM)274.92M
Net Income(TTM)-512.50M
Analysts46.15
Price Target2.7 (130.77%)
Short Float %9.86%
Short Ratio1.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-99.21%
Min EPS beat(2)-206.63%
Max EPS beat(2)8.22%
EPS beat(4)1
Avg EPS beat(4)-132.67%
Min EPS beat(4)-231.12%
Max EPS beat(4)8.22%
EPS beat(8)1
Avg EPS beat(8)-186.16%
EPS beat(12)2
Avg EPS beat(12)-180.17%
EPS beat(16)4
Avg EPS beat(16)-164.19%
Revenue beat(2)2
Avg Revenue beat(2)8.61%
Min Revenue beat(2)7.65%
Max Revenue beat(2)9.57%
Revenue beat(4)3
Avg Revenue beat(4)5.74%
Min Revenue beat(4)-0.3%
Max Revenue beat(4)9.57%
Revenue beat(8)5
Avg Revenue beat(8)3.48%
Revenue beat(12)7
Avg Revenue beat(12)1.93%
Revenue beat(16)8
Avg Revenue beat(16)-0.87%
PT rev (1m)-1%
PT rev (3m)23.4%
EPS NQ rev (1m)8.67%
EPS NQ rev (3m)29.78%
EPS NY rev (1m)0%
EPS NY rev (3m)-17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)9.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)10.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.03
P/FCF N/A
P/OCF N/A
P/B 1.14
P/tB 1.56
EV/EBITDA N/A
EPS(TTM)-3.04
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS0.58
BVpS1.03
TBVpS0.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -56.65%
ROE -104.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.83%
FCFM N/A
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 21.16%
Cap/Sales 3.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.07
Quick Ratio 2.12
Altman-Z -11.87
F-Score5
WACC11.44%
ROIC/WACCN/A
Cap/Depr(3y)15.39%
Cap/Depr(5y)45.04%
Cap/Sales(3y)2.72%
Cap/Sales(5y)9.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.25%
EPS Next Y87.72%
EPS Next 2Y39.4%
EPS Next 3Y25.31%
EPS Next 5Y15.29%
Revenue 1Y (TTM)-4.25%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%8.94%
Revenue Next Year8.32%
Revenue Next 2Y5.98%
Revenue Next 3Y7.52%
Revenue Next 5Y7.24%
EBIT growth 1Y47.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year86.74%
EBIT Next 3Y33.01%
EBIT Next 5Y21.01%
FCF growth 1Y76.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.03%
OCF growth 3YN/A
OCF growth 5YN/A

CANOPY GROWTH CORP / CGC FAQ

Can you provide the ChartMill fundamental rating for CANOPY GROWTH CORP?

ChartMill assigns a fundamental rating of 2 / 10 to CGC.


Can you provide the valuation status for CANOPY GROWTH CORP?

ChartMill assigns a valuation rating of 1 / 10 to CANOPY GROWTH CORP (CGC). This can be considered as Overvalued.


How profitable is CANOPY GROWTH CORP (CGC) stock?

CANOPY GROWTH CORP (CGC) has a profitability rating of 0 / 10.


What is the financial health of CANOPY GROWTH CORP (CGC) stock?

The financial health rating of CANOPY GROWTH CORP (CGC) is 3 / 10.